482 related articles for article (PubMed ID: 25572843)
1. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
[TBL] [Abstract][Full Text] [Related]
2. Impacts of the STING-IFNAR1-STAT1-IRF1 pathway on the cellular immune reaction induced by fractionated irradiation.
Du J; Kageyama SI; Yamashita R; Hirata H; Hakozaki Y; Okumura M; Motegi A; Hojo H; Nakamura M; Hirano Y; Sunakawa H; Minamide T; Kotani D; Tanaka K; Yano T; Kojima T; Ohashi A; Tsuchihara K; Akimoto T
Cancer Sci; 2022 Apr; 113(4):1352-1361. PubMed ID: 35133062
[TBL] [Abstract][Full Text] [Related]
3. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Stimulator of Interferon Genes (STING) Expression by Interferon-γ in Human Keratinocytes.
Nishikawa Y; Matsuzaki Y; Kimura K; Rokunohe A; Nakano H; Sawamura D
Biochem Genet; 2018 Apr; 56(1-2):93-102. PubMed ID: 29143896
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides.
Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C
PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993
[TBL] [Abstract][Full Text] [Related]
6. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
7. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression.
Nazmi A; Field RH; Griffin EW; Haugh O; Hennessy E; Cox D; Reis R; Tortorelli L; Murray CL; Lopez-Rodriguez AB; Jin L; Lavelle EC; Dunne A; Cunningham C
Glia; 2019 Jul; 67(7):1254-1276. PubMed ID: 30680794
[TBL] [Abstract][Full Text] [Related]
8. Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.
Zhang W; Jiang B; Zeng M; Duan Y; Wu Z; Wu Y; Wang T; Wang M; Jia R; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yu Y; Pan L; Chen S; Cheng A
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075929
[TBL] [Abstract][Full Text] [Related]
9. Functional crosstalk between type I and II interferon through the regulated expression of STAT1.
Gough DJ; Messina NL; Hii L; Gould JA; Sabapathy K; Robertson AP; Trapani JA; Levy DE; Hertzog PJ; Clarke CJ; Johnstone RW
PLoS Biol; 2010 Apr; 8(4):e1000361. PubMed ID: 20436908
[TBL] [Abstract][Full Text] [Related]
10.
Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
[TBL] [Abstract][Full Text] [Related]
11. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
[TBL] [Abstract][Full Text] [Related]
12. Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.
Goedegebuure RSA; Kleibeuker EA; Buffa FM; Castricum KCM; Haider S; Schulkens IA; Ten Kroode L; van den Berg J; Jacobs MAJM; van Berkel AM; van Grieken NCT; Derks S; Slotman BJ; Verheul HMW; Harris AL; Thijssen VL
J Exp Clin Cancer Res; 2021 May; 40(1):161. PubMed ID: 33964942
[TBL] [Abstract][Full Text] [Related]
13. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression.
Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W
Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
Urin V; Shemesh M; Schreiber G
J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
[TBL] [Abstract][Full Text] [Related]
16. RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection.
Liu Y; Goulet ML; Sze A; Hadj SB; Belgnaoui SM; Lababidi RR; Zheng C; Fritz JH; Olagnier D; Lin R
J Virol; 2016 Oct; 90(20):9406-19. PubMed ID: 27512060
[TBL] [Abstract][Full Text] [Related]
17. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
18. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
[TBL] [Abstract][Full Text] [Related]
19. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
